Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,802.00
Bid: 1,802.00
Ask: 1,804.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.111%)
Open: 1,780.00
High: 1,814.00
Low: 1,780.00
Prev. Close: 1,802.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

20 Sep 2011 15:07

RNS Number : 5938O
Genus PLC
20 September 2011
 

20 September 2011

 

Genus plc

 

('Genus' or 'the Company')

 

Director/PDMR Shareholding

 

 

Genus announces that of 117,359 ordinary shares of 10 pence each in the Company ("Ordinary Shares") which vested today in favour of Richard Wood, Chief Executive, under the Genus 2004 Performance Share Plan (the "Plan"), 117,359 Ordinary Shares were today sold on behalf of Richard Wood at a price of 1,000 pence per Ordinary Share.

 

Richard Wood's direct shareholding in the Company stands at 45,856 Ordinary Shares which represents 0.08% of the issued share capital of the Company which is currently 60,239,150 Ordinary Shares.

 

Genus also announces that of 46,927 Ordinary Shares that vested today in favour of Ian Biggs, Head of Global Product & Business Strategy, under the Plan, 46,927 Ordinary Shares were today sold on behalf of Ian Biggs at a price of 1,000 pence per Ordinary Share.

 

Ian Biggs' direct shareholding in the Company stands at 3,375 Ordinary Shares which represents 0.01% of the issued share capital of the Company. In addition, he remains the beneficial owner of 78,415 conditional nil-cost options under the Plan.

 

Of 41,061 Ordinary Shares that vested today in favour of Thomas Philip Acton, Chief Operating Officer of Europe & The Far East, under the Plan, 31,061 Ordinary Shares were today sold on behalf of Thomas Philip Acton at a price of 1,000 pence per Ordinary Share.

 

Thomas Philip Acton's direct shareholding in the Company now stands at 31,104 Ordinary Shares which represents 0.06% of the issued share capital of the Company. In addition, he remains the beneficial owner of 78,415 conditional nil-cost options under the Plan.

 

Of 28,156 Ordinary Shares that vested today in favour of Ian Farrelly, Group Company Secretary & General Counsel, under the Plan, 28,156 Ordinary Shares were today sold on behalf of Ian Farrelly at a price of 1,000 pence per Ordinary Share.

 

Ian Farrelly has no direct shareholding in the Company. He remains the beneficial owner of 61,462 conditional nil-cost options under the Plan.

 

Genus further announces that of 1,619 Ordinary Shares which vested today in favour of Bill Christianson, Chief Operating Officer, The Americas, under the Genus 2004 Executive Share Option Plan (the "ESOP"), 1,619 Ordinary Shares were today sold on behalf of Bill Christianson at a price of 1,000 pence per Ordinary Share.

 

Bill Christianson has no direct shareholding in the Company and is the beneficial owner of 56,953 conditional nil-cost options and 18,970 market value share options.

 

Of 6,673 Ordinary Shares which vested today in favour of David Crosby, Group Financial Controller, under the ESOP, 6,673 Ordinary Shares were today sold on behalf of David Crosby at a price of 1,000 pence per Ordinary Share.

 

David Crosby has no direct shareholding in the Company and is the beneficial owner of 53,843 conditional nil-cost options.

 

 

For further information please contact:

 

Cara Crichton

Assistant Company Secretary

Genus plc

 

Tel: 01256 345996

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSURRSRANAKUAR
Date   Source Headline
31st Jan 20065:06 pmRNSAdditional Listing
10th Jan 20063:12 pmRNSAdditional Listing
15th Dec 20056:34 pmRNSHolding(s) in Company
15th Dec 20056:20 pmRNSHolding(s) in Company
7th Dec 20057:01 amRNSDirectors' Share Awards
2nd Dec 20058:38 amRNSOffer Update
29th Nov 20057:02 amRNSInterim Results
25th Nov 200512:54 pmRNSOffer Update
22nd Nov 20057:02 amRNSOffer Update
18th Nov 20059:16 amRNSSchedule 1 - Genus PLC
14th Nov 200512:51 pmRNSOffer Update
11th Nov 20054:15 pmRNSRule 8.1- (Sygen)
8th Nov 20052:05 pmRNSOffer Update
4th Nov 20052:40 pmRNSRule 8.1- (Sygen)
3rd Nov 200512:48 pmRNSOffer Update
3rd Nov 20057:00 amRNSNotice of Interim Results
2nd Nov 20055:20 pmRNSRule 8.1- (Sygen)
2nd Nov 200510:19 amRNSOffer Update
1st Nov 20056:05 pmRNSRule 8.1- (Sygen)
1st Nov 200512:59 pmRNSOffer Document Posted
28th Oct 20055:48 pmRNSDisposal
28th Oct 20057:01 amRNSOffer for Sygen Int. plc
10th Oct 20057:00 amRNSPre-Close Trading Update
18th Aug 20054:13 pmRNSResult of AGM
18th Aug 20057:00 amRNSAGM Statement
19th Jul 200511:36 amRNSIssue of Equity
12th Jul 200512:31 pmRNSIssue of Equity
20th Jun 200511:37 amRNSIssue of Equity
8th Jun 20052:33 pmRNSIssue of Equity
24th May 20057:01 amRNSFinal Results
4th May 20054:59 pmRNSNotice of Results
2nd Mar 20055:33 pmRNSDirector Shareholding
19th Jan 20058:54 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.